Moxifloxacin and Breo ellipta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Moxifloxacin and Breo ellipta. Common interactions include general physical health deterioration among females and cough among males.

The phase IV clinical study analyzes what interactions people who take Moxifloxacin and Breo ellipta have. It is created by eHealthMe based on reports of 97 people who take Moxifloxacin and Breo ellipta from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 03, 2022

97 people who take Moxifloxacin and Breo ellipta together, and have interactions are studied.


What is Moxifloxacin?

Moxifloxacin has active ingredients of moxifloxacin. eHealthMe is studying from 9,510 Moxifloxacin users for its effectiveness, alternative drugs and more.

What is Breo ellipta?

Breo ellipta has active ingredients of fluticasone furoate; vilanterol trifenatate. It is often used in asthma. eHealthMe is studying from 30,675 Breo ellipta users for its effectiveness, alternative drugs and more.

Number of Moxifloxacin and Breo ellipta reports submitted per year:

Moxifloxacin and Breo ellipta drug interactions.

Common Moxifloxacin and Breo Ellipta drug interactions by gender *:

female:

  1. General physical health deterioration
  2. Hyperparathyroidism secondary
  3. Lacrimation increased
  4. Memory impairment
  5. Nephropathy toxic
  6. Nervousness
  7. Night sweats
  8. Oxygen saturation decreased
  9. Pleural effusion
  10. Psoriasis

male:

  1. Cough
  2. Dyspnoea
  3. Gait disturbance
  4. Haemoglobin decreased
  5. Haemoptysis
  6. Heart rate decreased
  7. Hilar lymphadenopathy
  8. Influenza
  9. Insomnia
  10. Liver disorder

Common Moxifloxacin and Breo Ellipta drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Bronchiectasis
  2. Cardiac murmur
  3. Gastrooesophageal reflux disease
  4. Lung neoplasm malignant
  5. Nasal polyps
  6. Oedema peripheral
  7. Rhinitis allergic
  8. Sarcoidosis
  9. Total lung capacity increased
  10. Wheezing

50-59:

  1. Tremor
  2. Anxiety
  3. Pneumonia
  4. Abdominal pain
  5. Abdominal pain upper
  6. Agitation
  7. Bronchitis
  8. Cystitis
  9. Depression
  10. Diarrhoea

60+:

  1. Cough
  2. Wheezing
  3. Nicotine dependence
  4. Secondary immunodeficiency
  5. Sputum purulent
  6. Dyspnoea
  7. Sleep disorder due to a general medical condition
  8. Blood pressure increased
  9. Atrial fibrillation
  10. Chest discomfort

Common conditions people have *:

  1. Urticaria (rash of round, red welts on the skin that itch intensely): 52 people, 53.61%
  2. Abdominal Pain: 51 people, 52.58%
  3. Depression: 51 people, 52.58%
  4. Stress And Anxiety: 51 people, 52.58%
  5. Stomatitis (inflammation of mucous membrane of mouth): 51 people, 52.58%
  6. Rashes (redness): 51 people, 52.58%
  7. Hallucinations (sensations that appear real but are created by your mind): 51 people, 52.58%
  8. Oesophageal Spasm (contraction of oesophagus): 51 people, 52.58%
  9. Nausea And Vomiting: 51 people, 52.58%
  10. Abdominal Pain Upper: 50 people, 51.55%

* Approximation only. Some reports may have incomplete information.

Do you take Moxifloxacin and Breo ellipta?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Moxifloxacin and Breo ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Moxifloxacin interactions:

Browse all interactions between Moxifloxacin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Breo ellipta interactions:

Browse all interactions between Breo ellipta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on moxifloxacin and fluticasone furoate; vilanterol trifenatate (the active ingredients of Moxifloxacin and Breo ellipta, respectively), and Moxifloxacin and Breo ellipta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Moxifloxacin and Breo ellipta.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: